Metrics question

What metrics would you use to judge whether a forward-deployed engagement was successful for both the health system partner and Abridge, and how would you balance adoption and workflow impact metrics against product quality, implementation effort, and evidence that the work should feed back into the core product?

Practice this question out loud. An AI interviewer asks it, follows up like a real interviewer would, and scores your answer. Type or speak.

What this question tests

Ability to define a two sided success framework for a services like engagement that must also justify itself as a product investment.

Define partner side success metrics: clinician adoption rate of the tool in real encounters, and a workflow impact metric like reduction in time spent on documentation, since that is the core value proposition.
Define the company side success metrics: implementation effort in engineering or forward deployed hours per outcome achieved, and product quality signals like note accuracy or clinician edit rate.
Set a bar for what counts as evidence the work should feed back into the core product, for example a workflow pattern or integration need that recurs across two or more partner engagements rather than being one off.
Balance the two sides explicitly: a highly customized engagement might show strong partner adoption but poor company side leverage if the effort cannot be reused, which counts against calling it a full success.
Track clinician trust indicators specifically, such as edit rate on generated notes, since documentation quality affects both adoption and clinical safety.
Review these metrics jointly at the end of the engagement to decide whether to continue as a manual deployment, invest in productizing the pattern, or wind down if effort and impact do not justify continuation.

Defines metrics on both sides explicitly, partner workflow impact and implementation leverage, rather than judging success from one side alone.
Names a concrete reuse threshold, the pattern recurring across multiple partners, before calling something a product requirement.
Uses clinician edit rate as a concrete quality and trust proxy for a clinical documentation product.
Explicitly weighs implementation effort against impact, avoiding calling a resource heavy one off engagement an unqualified success.

Judging success only by partner satisfaction without weighing the effort required or whether it can be reused.
No concrete reuse threshold for deciding something should feed the core product, treating every insight as a product requirement.

What would make you decide a successful engagement's approach should not be productized?
How would you measure clinician trust beyond edit rate?